328 W. Claiborne St.
P.O. Box 964
Monroeville, Alabama 36460
(251) 575-4203
Health Policy & Advocacy
Basic InformationMore InformationLatest News
Red Cross Needs Type O Blood to Ease ShortageLess Pain, More Car Crashes: Legalized Marijuana a Mixed BagPolitical Controversies Could Fuel Bullying of LGBT Youth: StudyCBD -- It's Everywhere, But Does It Work?Brief EMS Training Saves Lives After Brain InjuryU.S. Improves Emergency Readiness, but Gaps PersistSlowing Climate Change Could Cut Health Costs, Save MoneyDispensing Opioid Antidote Without a Prescription Might Save LivesNot Just Opioids: Deaths Tied to Cocaine, Meth Are Soaring, TooMost Americans Hit Hard by Medical BillsYour Virtual Doctor Will 'See' You NowHigh Measles Rates Mean Kids, Adults Need Proper Vaccination: CDCMany Drivers Testing Positive for Marijuana, Even With Kids in CarMedicaid Could Save $2.6 Billion a Year With Dip in SmokingFDA Halts All Sales of Pelvic Mesh Products Tied to Injuries in WomenAnother Cost of the Opioid Epidemic: Billions of Dollars in Lost TaxesHealth Tip: Using an AEDNurse Practitioners Often Restricted From Prescribing Opioid TreatmentsForested Counties Have Lower Medicare Costs, Study FindsSimple CPR Doubles Survival OddsUninsured Get Short Shrift on Hospital StaysSpecial Bag Helps Patients Get Rid of Unused OpioidsHealth Tip: Responsibilities of Non-VaccinationDo Doctors Hounded by Malpractice Claims Just Shift Their Practice Elsewhere?Bans on Texting While Behind the Wheel Making Roads SaferColorado Sees Spike in ER Visits After Pot Made LegalMajor Medical Groups Call for Soda TaxesCould the U.S. Mail Deliver Better Colon Cancer Screening Rates?Opioid Rxs Decreasing, But Not for All DoctorsAfter Chinese Infant Gene-Editing Scandal, U.S. Health Officials Join Call for a BanAre 'Inactive' Ingredients in Your Drugs Really So Harmless?Need to Be Vaccinated? Try Your Local PharmacyBystanders Key to Cutting Cardiac Arrest DeathsMany Black Americans Live in Trauma Care 'Deserts'FDA Issues Asbestos Warning About Some Claire's Cosmetic ProductsFDA to Crack Down on Retailers That Keep Selling Tobacco to KidsBlood Donation by Teen Girls May Raise Anemia RiskNurses' Long Hours, Moonlighting Could Pose Patient Safety RiskBerkeley's Efforts Suggest Soda Taxes Do Cut Soda SalesOpioid Overdose Deaths Quadruple, Centered in 8 StatesPayments for Research Can Lead to Lies: StudyFDA Aims to Strengthen Sunscreen RulesAre Primary Care Doctors Prepared to Discuss Cancer Treatment?FDA Fell Short in Preventing Fentanyl Abuse Crisis, Report ClaimsPrimary Care Doctors Help Boost Life Spans, But More Are NeededMore Car Crashes Tied to Drivers High on OpioidsPoor Whites Bear the Brunt of U.S. Opioid Crisis, Studies FindFDA to Tighten Oversight of SupplementsAs U.S. Measles Outbreaks Spread, Why Does 'Anti-Vax' Movement Persist?Even Brief EMS Delay Can Cost Lives After Car Crash
Related Topics

Health Insurance

Opioid Rxs Decreasing, But Not for All Doctors

HealthDay News
by By Serena GordonHealthDay Reporter
Updated: Mar 13th 2019

new article illustration

WEDNESDAY, March 13, 2019 (HealthDay News) -- Doctors may be pulling out their prescription pads less often for opioid medications, but not everyone's on the same page yet.

New research found that initial prescriptions for the addictive painkillers have dropped by around 50 percent.

"The good news is that we're making progress curtailing prescription opioids, but we have to temper our excitement because a large subgroup of providers is still using high-dose prescriptions or long prescriptions," explained senior study author Nicole Maestas.

And, "large numbers of providers stopped providing opioids at all. That could be good. But does this leave patients unable to get access to safe amounts of opioids when appropriate for pain control?" Maestas said. She's an associate professor at Harvard Medical School's department of health care policy.

The United States is in the middle of a devastating opioid epidemic. In 2016, more than 2 million Americans had an opioid use disorder. The opioid epidemic claims about 115 lives daily, many between the ages of 25 and 64, the study authors said.

One way that people become addicted is through the use of prescription opioids (such as OxyContin). Sometimes it's a prescription given to the person who becomes addicted. The researchers noted that prescription durations as short as six days have been linked to an increased risk of long-term opioid use. Another problem is that people get opioids from family or friends who haven't used their full prescription.

The U.S. Centers for Disease Control and Prevention has issued guidelines recommending that people receiving a first prescription for opioids should receive the lowest effective dose for the shortest time possible.

For the study, the researchers had access to a Blue Cross-Blue Shield commercial insurance database with more than 86 million people. The investigators looked at data between July 2012 and December 2017 for people aged 15 or older.

The findings showed that almost 20 million people received at least one opioid prescription during that time.

The researchers then looked at the rate of monthly prescriptions for people who had never had an opioid before or those who hadn't taken a prescription opioid in at least six months. They found the monthly rate of initial opioid prescriptions dropped from 1.6 percent in 2012 to 0.75 percent in 2017.

The study also found a 29 percent drop in the number of doctors who started opioid therapy in any patients.

On the flip side, risky prescribing persisted for some doctors, according to the report. More than 115,000 high-risk prescriptions were written per month. And almost 8,000 of these prescriptions were written for doses so high that they substantially increased the risk of overdose.

Dr. Lawrence Brown, CEO of START Treatment and Recovery Centers in New York City, said this study has some good news, but pointed out that it only looked at people with a particular commercial insurance. So, there's no information about people on Medicare and Medicaid, he said.

"This study gives us enough information to stimulate a discussion about the next steps, but we can't yet say we've turned a corner," Brown said.

So, what can be done to ensure providers are giving opioids to those who genuinely need them for pain, but doing so in a responsible manner?

Lead study author Wenjia Zhu, an associate in health care policy at Harvard Medical School, said, "The current opioid epidemic is a multi-faceted problem. There are no single solutions."

Zhu said that guidelines -- such as those from physicians' groups -- need to address opioid prescribing practices, and there's a need for increased education. She also said there needs to be increased insurance reimbursement for other pain management options.

Brown agreed and added that regulation, particularly at the state level, is another crucial component in attacking the opioid epidemic. "The driving force isn't the CDC, it's the states. States are the ones that license doctors, but state regulations tend to lag behind federal guidelines."

So, what can patients do in the meantime?

Maestas said that patients can bring up their concerns with their doctors. "Patients can ask their doctor for options. They can say don't start me on a high dose or don't give me so many pills," she said.

The study was published in the March 14 issue of the New England Journal of Medicine.

More information

Learn more about the opioid epidemic from the U.S. National Institute on Drug Abuse.

328 W. Claiborne St.
P.O. Box 964
Alabama 36460
Tel: (251)575-4203

powered by centersite dot net